Çok doruklu optimizasyon için particle swarm sistemleri
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
Many real world problems in science, engineering and economy, involve inoptimization. Multimodal optimization problems represent a subset of such problems,where the goal is to obtain multiple different solutions with equal (or preferable) quality ina single search space. Meta-heuristics, especially, evolutionary computation techniques arethe most commonly used approaches for solving difficult optimization problems. However,due to the multimodality, they might require some enhancements. Particle SwarmOptimizer (PSO), as a swarm intelligence technique, has proven its success in solvingoptimization problems. Additionally, several modified versions of the PSO algorithm makeit a good choice for attacking multimodal problems as well. In this thesis, the performanceof existing multimodal PSO techniques are analyzed over a set of well-known benchmarkfunctions. Moreover, a new PSO algorithm based on craziness and hill-climbing isproposed for solving multimodal optimization problems.
Author
Murat Yılmaz
How to Cite
Murat Yılmaz (Master Thesis). Çok doruklu optimizasyon için particle swarm sistemleri, 2006, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)